Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial VICCHN0530

Title

Serum Biomarkers for Head & Neck Cancer (deidentified)

Principal Investigator(s)

Wendell Yarbrough

Details

  • Protocol No. VICCHN0530
  • Open Date: 04/08/2005
  • Staging: N/A
  • Age Group: Adults
  • Scope: Local
  • Objective: Identify serum markers for the presence of head and neck squamous cell carcinoma (HNSCC)
  • Disease Sites: Head/Neck
  • Therapies: Correlative
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT00899769
  • Secondary Protocol No: Not Specified

Description

None Provided.

Eligibility

Ages Eligible for Study:18 Years and older
Genders Eligible for Study:Both
Accepts Healthy Volunteers:Accepts Healthy Volunteers

Criteria

DISEASE CHARACTERISTICS:
• Meets one of the following criteria:
• Diagnosis of squamous cell carcinoma of the head and neck
• Healthy volunteer matched by sex, race, birth decade, or smoking status (e.g., current smoker, former smoker, or nonsmoker)
PATIENT CHARACTERISTICS:
• Not specified
PRIOR CONCURRENT THERAPY:
• Not specified